QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.074021v1 312/1/77    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Itagaki, S. Articles by Iseki, K. Search for Related Content PubMed PubMed Citation Articles by Itagaki, S. Articles by Iseki, K.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

H⁺-Dependent Transport Mechanism of Nateglinide in the Brush-Border Membrane of the Rat Intestine

Department of Clinical Pharmaceutics and Therapeutics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Japan

(–)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine (nateglinide) is a novel oral hypoglycemic agent possessing a carboxyl group and a peptide-type bond in its structure. Although nateglinide quickly reaches the maximal serum concentration after oral administration, nateglinide itself is not transported by PepT1 or MCT1. The aim of this study was to characterize the transporters on the apical side of the small intestine that are responsible for the rapid absorption of nateglinide. The uptake of nateglinide by rat intestinal brush-border membrane vesicles is associated with a proton-coupled transport system. Ceftibuten competitively inhibited H⁺-dependent nateglinide uptake. Glycylsarcosine (Gly-Sar), cephradine, and cephalexin did not significantly inhibit the uptake of nateglinide. The combination of Gly-Sar and nateglinide greatly reduced the uptake of ceftibuten. The effect of the combined treatment was significantly greater than that of Gly-Sar alone. Furthermore, nateglinide competitively inhibited H⁺-driven ceftibuten transporter-mediated ceftibuten uptake. Ceftibuten transport occurs via at least two H⁺-dependent transport systems: one is PepT1, and the other is the ceftibuten/H⁺ cotransport system. On the other hand, we demonstrated that nateglinide transport occurs via a single system that is H⁺ dependent but is distinct from PepT1 and may be identical to the ceftibuten/H⁺ cotransport system.

Address correspondence to: Dr. Ken Iseki, Department of Clinical Pharmaceutics and Therapeutics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan. E-mail: ken-i{at}pharm.hokudai.ac.jp